Recent data have suggested interferon-gamma (IFN-γ) and/or interleukin-2 (IL-2) to be protective rather than pro-inflammatory cytokines that could be involved in the down-regulation of RA-related chronic inflammation [4, 5]. The gene discussed is IFNG; the disease is inflammation.